Management of Metastatic Bone Disease in the Elderly with Bisphosphonates and RANKL Inhibitors: Effectiveness and Safety

2013 ◽  
pp. 365-379
Author(s):  
Vassilios Vassiliou ◽  
Panteleimon Kountourakis ◽  
Dimitrios Kardamakis
Keyword(s):  
Bone Disease ◽  
The Elderly ◽  
Metastatic Bone Disease

Metastatic bone disease in patients with neuroendocrine tumors

2014 ◽  
Author(s):  
Krystallenia Alexandraki ◽  
Maria Chrysochoou ◽  
Maria Kaltsatou ◽  
Eleftherios Chatzellis ◽  
Marina Tsoli ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Bone Disease ◽  
Metastatic Bone Disease

scholarly journals Surgical Treatment of Metastatic Bone Disease—When Decisions at End-of-Life Really Makes the Difference

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2581
Author(s):  
Michala Skovlund Sørensen ◽  
Michael Mørk Petersen
Keyword(s):  
Surgical Treatment ◽  
End Of Life ◽  
Bone Disease ◽  
Paradigm Shift ◽  
Metastatic Bone Disease ◽  
The Difference

The current era within the field of surgical treatment of metastatic bone disease (MBD) is best described as the beginning of a paradigm shift [...]

Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease

1983 ◽  
Vol 308 (25) ◽  
pp. 1499-1501 ◽  
Author(s):  
André Jung ◽  
Alex Chantraine ◽  
Alfred Donath ◽  
Christiana van Ouwenaller ◽  
Dora Turnill ◽  
...  
Keyword(s):  
Bone Disease ◽  
Metastatic Bone Disease ◽  
Dichloromethylene Diphosphonate

Metastatic Bone Disease

2003 ◽  
Vol 2 (4) ◽  
pp. 269-281 ◽  
Author(s):  
Janet E Brown ◽  
Robert E Coleman
Keyword(s):  
Bone Disease ◽  
Metastatic Bone Disease

The role of vitamin D and related compounds in the treatment of bone disease in the elderly

Bone ◽  
1994 ◽  
Vol 15 (6) ◽  
pp. 727-728 ◽  
Author(s):  
J.A. Kanis ◽  
C. Cooper ◽  
R. Francis ◽  
N. Hamdy ◽  
P. Selby ◽  
...  
Keyword(s):  
Vitamin D ◽  
Bone Disease ◽  
The Elderly ◽  
Related Compounds
Sign in / Sign up

Export Citation Format

Share Document